Oncologist Dr Julie Nangia sits down with oncology thought leaders from Japan, Germany, and South Korea, to discuss what unites their cancer care practice – prescribing scalp cooling for patients on anthracycline regimens.
Despite hair retention with scalp cooling on anthracycline regimens generally being lower in comparison to taxanes, the group discuss why having a ‘taxanes only’ mentality is limiting patient choice. They argue that ‘successful’ hair retention is subjective, and rates that might be seen as a failure by a physician may be seen as successful by a patient. They also discuss the faster hair regrowth benefits of scalp cooling, the longer-term effects of which can motivate patients to continue with scalp cooling even if significant hair loss is sustained, helping patients move on from treatment faster.
0:3:26 - The panel discuss dispelling myths around scalp cooling with Anthracyclines
04:47 - Dr Julie Nangia discusses The SCALP Study
8:55 - Each panellist discusses their experiences of hair retention with Anthracyclines
13:05 - Mary Fay outlines reasons for clinical pushback of scalp cooling
15:01 - Dr Christian Kurbacher describes protocols for scalp cooling with Anthracyclines in Germany
16:21 - Mary Fay discusses anecdotal evidence for increased hair regrowth with scalp cooling
18:47 - Dr Julie Nangia explains in The SCALP Study, one patient experienced hair regrowth whilst still going through chemotherapy treatment
21:02 - Managing patients who have had low hair retention
21:32 - Dr Julie Nangia discusses scalp cooling reimbursement
23:13 - Dr Takayuki Kinoshita discusses permanent chemotherapy-induced alopecia evident in Taxane-based therapies
24:46 - The international panel discuss the anthracycline chemotherapies used in their retrospective countries
Dr Julie Nangia, Mary Fay RN, Dr Taka Kinoshita, Dr Christian Kurbacher and Dr Jin Soek Ahn.
Kinoshita T, et al. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study. Front Oncol. 2019 Aug 6;9:733.
Ohsumi S, et al. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy. Support Care Cancer. 2021 Jan;29(1):437-443.
van den Hurk CJ, et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncol. 2012 Apr;51(4):497-504.
Rice BA, et al. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2018 Jan;167(1):117-122.
Oncologist Dr Julie Nangia sits down with oncology thought leaders from Japan, Germany, and South Korea, to discuss what unites their cancer care practice – prescribing scalp cooling for patients on anthracycline regimens.
Despite hair retention with scalp cooling on anthracycline regimens generally being lower in comparison to taxanes, the group discuss why having a ‘taxanes only’ mentality is limiting patient choice. They argue that ‘successful’ hair retention is subjective, and rates that might be seen as a failure by a physician may be seen as successful by a patient. They also discuss the faster hair regrowth benefits of scalp cooling, the longer-term effects of which can motivate patients to continue with scalp cooling even if significant hair loss is sustained, helping patients move on from treatment faster.
Oncologist Dr Julie Nangia sits down with oncology thought leaders from Japan, Germany, and South Korea, to discuss what unites their cancer care practice – prescribing scalp cooling for patients on anthracycline regimens.
Despite hair retention with scalp cooling on anthracycline regimens generally being lower in comparison to taxanes, the group discuss why having a ‘taxanes only’ mentality is limiting patient choice. They argue that ‘successful’ hair retention is subjective, and rates that might be seen as a failure by a physician may be seen as successful by a patient. They also discuss the faster hair regrowth benefits of scalp cooling, the longer-term effects of which can motivate patients to continue with scalp cooling even if significant hair loss is sustained, helping patients move on from treatment faster.
0:3:26 - The panel discuss dispelling myths around scalp cooling with Anthracyclines
04:47 - Dr Julie Nangia discusses The SCALP Study
8:55 - Each panellist discusses their experiences of hair retention with Anthracyclines
13:05 - Mary Fay outlines reasons for clinical pushback of scalp cooling
15:01 - Dr Christian Kurbacher describes protocols for scalp cooling with Anthracyclines in Germany
16:21 - Mary Fay discusses anecdotal evidence for increased hair regrowth with scalp cooling
18:47 - Dr Julie Nangia explains in The SCALP Study, one patient experienced hair regrowth whilst still going through chemotherapy treatment
21:02 - Managing patients who have had low hair retention
21:32 - Dr Julie Nangia discusses scalp cooling reimbursement
23:13 - Dr Takayuki Kinoshita discusses permanent chemotherapy-induced alopecia evident in Taxane-based therapies
24:46 - The international panel discuss the anthracycline chemotherapies used in their retrospective countries
Dr Julie Nangia, Mary Fay RN, Dr Taka Kinoshita, Dr Christian Kurbacher and Dr Jin Soek Ahn.
Kinoshita T, et al. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study. Front Oncol. 2019 Aug 6;9:733.
Ohsumi S, et al. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy. Support Care Cancer. 2021 Jan;29(1):437-443.
van den Hurk CJ, et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncol. 2012 Apr;51(4):497-504.
Rice BA, et al. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2018 Jan;167(1):117-122.
